Purpose: To correlate the X inactivation pattern, as determined by one or more molecular assays, with phenotype in individuals with structurally abnormal X chromosomes. Methods: We utilized methylation analysis of androgen receptor (AR) and Fragile X (FMR1) genes and expression studies of an XlST polymorphism to assess X inactivation patterns of 28 females with structurally abnormal X chromosomes. Individuals were placed in one of three categories: (1) completely nonrandom inactivation of one X chromosome, (2) preferential or skewed inactivation of one X chromosome, or (3) random inactivation of either X chromosome. Results: In 19 of 2 1 cases with complete (>97%) skewing of X inactivation, the phenotype was either normal, consistent with a single gene disorder, or consistent with classical Turner syndrome; two cases with completely nonrandom X inactivation had unexplained mental retardation phenotypes. In contrast, six of seven cases that did not exhibit completely nonrandom X inactivation were phenotypically abnormal. Carriers of two balanced translocations, two duplicated X s , one deleted X, and one 45,X/46,X,r(X) presented with mental retardation and/or multiple congenital anomalies. Conclusion: In patients with random or skewed X inactivation, the abnormal phenotype was hypothesized to be due to functional nullisomy or disomy of X-linked genes. Based on these results, we propose that X inactivation studies should be performed on all women with structurally abnormal X chromosomes. This should aid in the understanding of abnormal phenotypes in liveborn individuals with abnormal X chromosomes and may help to predict phenotypes for prenatally detected cases in the future. Genetics in Medicine, 2000:2(2):136-141.
In chromosomally normal mammalian females, one of the two X chromosomes becomes randomly inactivated early in embryogenesis to allow for dosage compensation of X-linked genes between XX females and XY ma1es.l The selection of which X is inactivated is random in the normal situation, and once made, the inactivation pattern is maintained and inherited in the clonal descendants of the precursor cell.' Random inactivation generally results in approximately equal numbers of cells with inactivation of the maternal or paternal X chromosome.
Nonrandom or skewed X inactivation is the result of one X chromosome becoming inactivated in most or all of the female's cells. There is a very small chance that extremely skewed X inactivation may arise by chance, due to stochastic variation, but completely nonrandom inactivation is more commonly observed as the result of a secondary selection against cells carrying a genetic alterati~n.'.~ Recently, skewing of X inactivation has also been shown to arise from a primary effect of the X inactivation process.5 Secondary cell selection has been documented in women who carry X-linked disease and in women who carry structurally abnormal X chromos o m e~.~~-~~ In women with abnormal X chromosomes, this selection against one cell line ensures maintenance of the most genetically "balanced" situation, and these women are usually phenotypically normal or present with features of Turner syndrome. l 2 3 l 4 Historically, late replication banding has been used to assess the X inactivation pattern in women with structurally abnormal X chromosomes.15 This technically challenging and subjectively interpreted testing modality is not routine for most clinical cytogenetic laboratories. While late replication banding has the advantage of allowing for the identification of the chromosome inactivated, this method is not useful for cases with a low mitotic index or for cases with subtle aberrations in which the X chromosomes are not easily distinguishable cytologically. Recently, several quantitative molecular methods have been described to directly assess X inactivation patterns.I6-l8 Molecular methods sample material (DNA or RNA) isolated from a large population of cells, yielding a cost-effective test that is likely to be more reflective of an individual's true X inactivation pattern than assays based on the analysis of Genetics IN ?.4edicine <I00 cells. We have studied 28 females with structurally abnormal X chromosomes using three molecular techniques (methylation analysis at the AR and/or FMRl loci and expression of an XIST polymorphism) to evaluate the X inactivation pattern. This data were used to correlate the phenotype of the cases with the X inactivation pattern.
MATERIALS AND METHODS

Patient samples and cell lines
The X inactivation patterns of 28 females with structurally abnormal X chromosomes were assayed (Table 1) . These included 15 women with balanced X/autosome translocations (cases #1-15); threewith a deleted X (cases #16-18); three with aduplicated X (cases #19-21); three with an isochromosome X (cases #22-24); and four with small ring X chromosomes (cases #25-28) (Table 1) . For some cases, cell lines were purchased from Coriell Human Genetic Cell Repository (Table 1 ; http:// locus.umdnj.edu/nigms/sitemap.html).
Methylation analyses of androgen receptor and FMRl
X inactivation patterns of women with an abnormal X chromosome were assayed via methylation of androgen receptor (AR) and the Fragile X mental retardation gene (FMR1). For AR analysis, methylation of the CpG island adjacent to the polymorphic CAG repeat in exon 1 of the gene was evaluated essentially according to the method described by Allen et a1.16 The FMRl analysis was performed according to the method of Carrel and Willard." For both methods, DNAs from the patient and appropriate controls were digested with the methylation-sensitive enzyme HpaII along with RsaI, which allows for more thorough HpaII digestion. To ensure complete digestion of the sample, additional HpaII was added the following morning following the overnight digestion, and the samples were incubated for an additional 2 hours. Digested and undigested DNA samples were PCR amplified using a 3 2~ end-labeled forward primer. Samples were loaded onto a 6% acrylamide gel and electrophoresed. X inactivation ratios were determined using visual comparison of the cut and uncut samples.
X inactivation ratios were also assessed by comparing the ratios of an expressed polymorphism in the XIST gene,I8 as described in Carrel et al., 1999.19 Patient cDNA was amplified for 29 cycles, followed by a single cycle primer extension using a 32~-labeled forward primer. The PCR products were digested with Hinfl and were electrophoresed in a 6% polyacrylamide gel. Relative expression of each XIST allele was determined visually.
For the three methods, X inactivation patterns were divided into three readily-distinguishable categories, based on visual inspection: (1) completely nonrandom inactivation (with no detectable band for one allele, e.g., pt. # 13, Fig. l) , (2) skewed inactivation (with easily detectable differences between two bands, e.g., pt. #19, Fig. I ), and (3) random X inactivation (with no visible difference between the band intensities, e.g., pt. #18, Fig. 1 ). The X inactivation pattern was considered "completely nonrandom" if only one band of a heterozygous individual was visualized on an overexposed autoradiograph using one or more of the methods described. A monoallelic amplification pattern was indicative of complete inactivation of either the maternal or paternal chromosome. Because an X inactivation ratio of 973 revealed two visible alleles, as determined using titration analyses (L.C., unpublished data), the sensitivity was demonstrated to be >97%.
RESULTS
Completely nonrandom X inactivation was demonstrated for eight phenotypically normal carriers of aberrant X chromosomes (Table 1 ) including six carriers of balanced translocations involving the X chromosome (cases #1, 2, 3, 11, 12, 13) (case #13, Fig. l) , and two carriers of deleted X chromosomes (cases #16, 17) ( Table 1 ). Completely nonrandom inactivation was also observed in five individuals with a breakpoint-associated single gene disorder and a balanced Wautosome translocation (case #4 -X-linked hypohidrotic ectodermal dysplasia, case #5 -Duchenne muscular dystrophy (DMD), case #8 -Klippel Feil syndrome, case #9 -sporadic retinoblastoma, case #10 -DMD). Case #7, with secondary amenorrhea and a balanced Wautosome translocation, exhibited the predicted completely nonrandom X inactivation pattern, as did six individuals with Turner syndrome, three with an isochromosome X (cases #22, 23, 24) and three with small ring(X) chromosomes (cases #25, 26, 27) . Two cases with completely nonrandom X inactivation had mental retardation of unexplained origin (cases #7 and 25). Late replication data available from lymphocyte analysis of nine cases with completely nonrandom X inactivation revealed a 100% correlation (Table 1) .
Seven cases did not show completely nonrandom X inactivation, such that a proportion of cells were either monosomic or disomic for X-linked genes ( Table 1) . Six of these individuals were reported to be phenotypically abnormal; #19, who had a small duplication of Xq, had a percentage of cells with an active abnormal X, but exhibited a normal phenotype (Fig. 1 ).
Two cases with apparently balanced Wautosome translocation~, case #14 -t(X; 17)(qll; q l l ) and case#15 -t(X; 9)(q28; q21), exhibited a skewed and random X inactivation pattern, respectively. The patient with the X; 17 translocation had multiple severe congential anomalies that did not conform with any known syndrome, and the patient expired on day 17 (see Disteche et al. for additional clinical information). FMRl methylation studies revealed that this patient had both alleles present in the HpaII-digested lane, however, one allele was reduced in intensity. This skewed X inactivation pattern correlated with previously reported late replication studies20 that demonstrated approximately 20-40% of cells analyzed had an inactivated derivative chromosome, with no apparent spreading into the autosomal material. This result is consistent with a significant percentage of this patient's cells being functionally disomic for all of Xp and a portion of Xq.
Likewise, the patient with an apparently balanced X; 9 translocation (case #15) was functionally disomic for Xq28-qter in a proportion of her cells. FMRl and AR methylation studies re- cases with late replication study results reported by the source, the ratios are given, along with the data on the identity of the late replicating chromosome. some cases had subtle abnormalities that did not allow for the Xs to be discriminated. vealed a random pattern ofX inactivation in this patient's lymp h o c y t e~.~~ Case #15 exhibited dysmorphic features and was mentally impaired.21 While the molecular data suggested random X inactivation, late replication studies of a limited amount of cells (N = 25) revealed a skewed pattern of X inactivation with 84% of cells exhibiting inactivation of the normal X.2' Case #18, with a Xq27.3 -q28.3 deletion, exhibited an abnormal phenotype with mental and growth retardation, seizures, and dysmorphic features.22 Both FMRl and AR methylation analyses revealed a random X inactivation pattern (case #18, Fig. 1 ). Late replication studies were not useful in this case because the Xs could not be distinguished in the banded prep-' a r a t i o n~.~~ A skewed X inactivation pattern was seen for all three of the X duplication cases (#19, 20, 21), suggesting that, at least in a percentage of cells, these patients were disomic for X sequences. One case was phenotypically normal (#19). One case (#20) had a duplication of Xq2 1.2 -q22.1 and presented with growth retardation and developmental delay. Case #2 1, with a duplication Xq13.1 -q24, also had an abnormal phenotype.
Generally, a patient with a small ring X chromosome presents a special case. Because several small marker X chromosomes that hybridize with an XIST DNA probe have been shown to be active,23 the androgen receptor assay may be used to see if the alleles from both the normal and the small marker X chromosome are expressed. (XIST and FMRl assays may not be helpful because they may not be present on the tiny marker chromosomes.) We used this analysis to study 4 patients with the karyotype 46,X,r(X): two cases (#25 and #28) with an abnormal phenotype and two cases (#26 and #27) with a typical Turner syndrome phenotype. Cases #25,26, and 27 revealed a pattern consistent with completely nonrandom X inactivation (only one allele detectable; Fig. 2) , and each of these cases was positive for XIST DNA using FISH (data not shown). No alleles were detected in the digested sample from case #28 (although DNA was readily amplified from an unrelated locus), consistent with both the normal X and the r(X) being active. This case was shown to be deleted for XIST DNA (data not shown). Thus, the molecular assay concurred with the XIST DNA FISH results. These results reveal that case #25 appropriately inactivated the ring X; therefore, the abnormal phenotype in this patient is not likely to be due to overexpression of X-linked genes X inactivation, in the normal situation, is random with respect to which X chromosome in the cell is inactivated. Extreme nonrandom X inactivation may reflect a bias in the initial choice, such as the imprinted inactivation ofthe paternal X in extra-embryonic tissues of the mouse or may be the result of selective press~res.~ In patients with structurally abnormal X chromosomes, initially X inactivation is random; however, cell selection, to ensure the most genetically balanced situation, occurs in the majority of case^.'^.^^ We have studied the X inactivation patterns of 28 women with structurally abnormal X chromosomes. For the majority of cases with a normal phenotype, a Turner syndrome phenotype, or a single-gene disorder phenotype, completely nonrandom X inactivation was demonstrated, consistent with the expected cell selection phenomenon. However, 6 of 7 women with a skewed or random pattern had nonspecific mental retardation and/or congenital abnormalities. These data confirm a correlation between phenotype and the X inactivation pattern as was reviewed by Schmidt and Du Sart.I2
Early evaluations of X inactivation patterns used late-replication banding15 or protein isozyrne studies25 to determine ratios of inactivation in women. Late replication, an interpretive test lacking sensitivity, and protein polymorphism analysis, a test with limited utility due to low heterozygosity, were not useful for the study of all of the females with structurally abnormal X chromosomes. More recently, several molecular methods have been described to directly assess X inactivation patterns.16,17-l9 These methodologies have the advantages of high heterozygosity and the ability to evaluate material from a large numbers of cells leading to increased sensitivity. The major disadvantages of molecular testing are the inability to identify which X is inactive (normal or abnormal) and the lack of detection of spreading of X inactivation into autosomal material. Thus, when inactivation is completely nonrandom, it is unclear which Xis inactive in every cell. It is presumed that the skewing is toward the most "genetically balanced" situation. In carriers of a structurally abnormal X chromosome that exhibit skewed or random X inactivation, as evaluated by molecular techniques, functional disomy or monosomy of X chromosomal sequences may be correlated with an anomalous phenotype. For cases ofXlautosome translocations, additional information from complementary late replication studies would be useful to further indicate possible abnormal dosage of autosomal genes.
For our study and previous X inactivation studies, the correlation of phenotype and X inactivation pattern is limited by the study of one (at most two) tissue types. In addition, not all clinically relevant cell lineages (for example, brain) may be studied. However, for the majority of cases for which multiple tissues (e.g., blood and skin) have been assayed, the X inactivation patterns are consistent.12 For eight of our cases, late replication studies on lymphocytes correlated exactly with the molecular findings on fibroblast tissue (Table 1, cases #1,3,5, 7-10,22) . Significant differences in X inactivation patterns in various tissues from an individual have been reported rarely.20. 26 Our results suggest that, although the finding of a completely nonrandom pattern in a single tissue of an individual with a structurally abnormal X chromosome cannot ensure a good outcome, a documented random inactivation pattern in a single tissue from a female with a structurally abnormal X may indicate a significant disomy or monosomy of X-linked sequences. For clinical utility of molecular testing, it would be advantageous to sample multiple tissues prior to risk evaluation.
Thirteen of the samples tested were cultured fibroblasts (Table 1). Cultured cells are not the optimal specimen for molecular testing of X inactivation given the chance of clonality. However, fibroblast cultures, unlike lymphoblast cultures, are outgrowths from a large number of cells and are therefore likely oligoclonal. The majority of cultures analyzed were of a relatively low passage number (< 10) and therefore most likely were not clonal. For clinical testing, fresh blood and/or other tissue should be assayed.
One case (#19) with a small duplication of Xq revealed a skewed X inactivation pattern and a normal phenotype. This individual thus had a population of cells with disomy of Xq26.3q27.2. While the majority of cytogenetically evident duplications of chromosomal material result in an abnormal phenotype, there have been several reports of autosomal duplications in normal individuals.27-29 It has been hypothesized that increased dosage of small amounts of specific genetic material may be tolerated by cells and not interfere with normal development. Two other cases (#20, 21) with small duplications and skewed X inactivation patterns did exhibit an abnormal phenotype. Thus, correlations of X inactivation pattern and phenotype in patients with small duplications should be interpreted with care.
Patients with small ring X chromosomes are often divided into two categories based upon the presence or absence of the XIST gene DNA.30-32 While this association holds true for the majority of cases, a molecular analysis of gene expression and/or activity offers the advantage of assessing specific genes on the ring X. This testing may be particularly useful in cases that are positive for XIST DNA, but do not express XIST appropriately. 22 Our results demonstrated concordance between the XIST DNA FISH and the molecular assays. In addition, one patient with a ring X and an abnormal phenotype (case #25) had a pattern consistent with normal XIST expression. Therefore this patient's abnormal phenotype is most llkely unrelated to the abnormal karyotype.
For 9 of our cases, two or three methods were used to assess X inactivation pattern (Table 1 ). The assays gave consistent results between the various testing methods, suggesting that a single test method d yield reliable X inactivation results. It is important to note that the methylation assays are performed on extracted DNA; whereas, cDNA from isolated RNA is needed for the XIST assay. Therefore, clinical laboratories will need to weigh the utility of each extraction and testing methodology.
While molecular determination of the X inactivation ratio is not technically difficult and is of clinical importance, several factors should be considered when performing these assays and interpreting the clinical significance. Complete restriction enzyme digestion for the methylation assays must be documented, because incomplete digestion will give a result compatible with random X inactivation. To ensure complete digestion for our studies, we included RsaI in the HpaII digestions, we doubled the amount of HpaII routinely used for digestion, and we included at least two male controls with each assay.
The informativeness of the gene polymorphisms is an additional consideration. The androgen receptor is polymorphic in approximately 70% of women.I6 The informativeness of the repeat in FMRl and the expressed XIST polymorphism are somewhat less, 65% and 50%, re~pectively.'8-~~ Thus, it is advantageous to have the capability of performing several assays to increase the l~kelihood of finding informative polymorphism~ for the majority of cases.
The 28 cases presented here represent a biased population of women with structurally abnormal X chromosomes. The majority of our cases were obtained from the NIGMS Mutant Cell Repository or from clinical cytogenetic laboratories that referred interesting cases for evaluation. Thus, it may be presumed that most women with structurally abnormal Xs will present with nonrandom X inactivation. However, in patients with a structurally abnormal X and an unexplained aberrant phenotype, X inactivation studies are warranted.
There is currently no literature on prenatal X inactivation studies and correlation with phenotype. Again, it is presumed that the majority of female fetuses with structurally abnormal X chromosomes will undergo cell selection, and thus, exhibit a Genetics IN Medicine '0 completely nonrandom X inactivation pattern. Prospective X 'b inactivation studies will need to be performed on prenatal samples to assess the feasibility and utility of testing all female 4 fetuses with structurallv abnormal X chromosomes.
Our studies indicate that the X inactivation status ofwomen with structurally abnormal X chromosomes and an abnormal 101 phenotype should be assayed as part of a routine clinical workni : up. While the clinical significance of slight variations in X inactivation patterns has not been evaluated, our data reveal that 1 1 the phenotype may be correlated with easily detectable differ-! [ ences in the X inactivation ratios. Clearly, the intensities of nt bands demonstrating nonrandom X inactivation, random X j inactivation, and skewed X inactivation are readily visually disy. tinguishable, and the clinical correlations may be made using rc these distinctions. Further studies are needed to evaluate the relevance of more subtle variations in the X inactivation pat-, ! terns.
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